Case Study: How Altasciences Launched a Phase I Study 70% Faster Than the Industry Standard
Clinical trial start-up is a critical phase that carries many risks of delay, that can adversely impact the study timelines and budget. Altasciences was able to achieve an expedited project launch from the typical 12-week start-up process to just 3.5 weeks for a client by aligning our internal team on all objectives, engaging in open dialogue with the sponsor, and optimizing project management by assigning two project leads in two different time zones.
Case Study—Gene Therapy and Stem Cell Transplantation Via MRI-Guided Intraparenchymal Delivery Into Brain Regions (Cortical and Subcortical)
Case Study—Driving Simulator Assessment
Lipid Nanoparticles: A Comprehensive Assessment of Liver Enzymes and Immunopathology Markers in Nonhuman Primates
Leveraging Nonclinical Safety Evaluation Findings to Expedite Next-Generation Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) Development for Metabolic Disorders and Beyond
Intravenous Sampling and Administration Using InstechVascular Access Buttons in Rodents: Pathology Findings Related to Indwelling Vascular Catheter
Intra-Cerebroventricular (ICV) Route in Mice for Administration of Gene Therapy Products
Immunomodulatory Approaches in Preclinical Gene Therapy Studies
An Examination of the Effects of Body Temperature on QT Interval in Non-Naïve Telemetered Göttingen Minipigs®